Should Catheter Ablation for Atrial Fibrillation be a Priority in Patients with Heart Failure with Reduced Ejection Fraction?

The management of atrial fibrillation in patients with heart failure (HF) has been an on-going challenge, no clear evidence for a rhythm control strategy until recent clinical trials using catheter ablation. Recently, the RAFT-AF study (randomized ablation-based rhythm-control versus rate-control trial and fibrillation; ClinicalTrials.gov identifier: NCT01420393) was published suggesting benefit ablation HF reduced ejection fraction. data from this pivotal are reviewed placed into context other important trials. Taken together, these studies make strong argument considering but not preserved